News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gould Robert J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| Gould Robert J (Interim President & CEO) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.16, valued at
$94.8k
|
|
| 01/13/2023 |
4
| Gould Robert J (Interim President & CEO) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 6,766 shares
@ $15, valued at
$101.5k
|
|
| 06/29/2022 |
4
| Gould Robert J (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 19,000 options to buy
@ $5.22, valued at
$99.2k
|
|
| 06/08/2022 |
4
| Gould Robert J (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 71,435 shares
@ $8.0898, valued at
$577.9k
Exercised 71,435 options to buy
@ $7.84, valued at
$560.1k
|
|
| 06/06/2022 |
4
| Gould Robert J (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 16,689 shares
@ $7.9191, valued at
$132.2k
Sold 25,551 shares
@ $7.9471, valued at
$203.1k
Sold 24,382 shares
@ $8.104, valued at
$197.6k
Exercised 16,689 options to buy
@ $7.84, valued at
$130.8k
Exercised 25,551 options to buy
@ $7.84, valued at
$200.3k
Exercised 24,382 options to buy
@ $7.84, valued at
$191.2k
|
|
| 04/11/2022 |
4
| Gould Robert J (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 5,631 shares
@ $24.015, valued at
$135.2k
Exercised 5,631 options to buy
@ $7.84, valued at
$44.1k
|
|
| 04/05/2022 |
4
| Gould Robert J (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 34,464 shares
@ $24.0297, valued at
$828.2k
Sold 7,235 shares
@ $24.0151, valued at
$173.7k
Sold 52,552 shares
@ $24.2574, valued at
$1.3M
Exercised 34,464 options to buy
@ $7.84, valued at
$270.2k
Exercised 7,235 options to buy
@ $7.84, valued at
$56.7k
Exercised 52,552 options to buy
@ $7.84, valued at
$412k
|
|
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $12.0826, valued at
$120.8k
|
|
| 07/09/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $20, valued at
$50k
|
|
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 156 shares
@ $20, valued at
$3.1k
|
|
| 06/09/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 3,433 shares
@ $20.1722, valued at
$69.3k
|
|
| 06/05/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $20.1283, valued at
$30.2k
Sold 1,300 shares
@ $20.0446, valued at
$26.1k
|
|
| 06/03/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 5 shares
@ $20, valued at
$100
Sold 2,797 shares
@ $20, valued at
$55.9k
|
|
| 06/01/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 1,919 shares
@ $20.0058, valued at
$38.4k
Sold 1,390 shares
@ $20.0797, valued at
$27.9k
|
|
| 05/28/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $20, valued at
$50k
|
|
| 02/20/2020 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $20, valued at
$50k
|
|
| 01/27/2020 |
4
| Gould Robert J (President & CEO) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $16.87, valued at
$3.4M
|
|
| 07/18/2019 |
4
| Gould Robert J (See Remarks) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 107,142 options to buy
@ $16, valued at
$1.7M
|
|
|
|